As Partner and CFO of Hitachi Ventures, Wolfgang has been a driving force since the formation of Hitachi Ventures, and has led many of its investments in Digital, DeepTech and Healthcare.
Wolfgang has managed and run successful international VC and Private Equity funds for over two decades. Prior to Hitachi Ventures he was Managing Partner for AGIC Capital, a billion-dollar PE fund investing in Industrial, Medical and Digital Technologies. And before that he was a partner at Earlybird, investing in Fintech, B2B SaaS, Semiconductor and Environmental Technologies.
For many years Wolfgang served on boards of industry associations such as the German Venture Capital and Private Equity Association (BVKAP), Munich Network, CTI Invest and others.
Wolfgang studied Physics and Mathematics in Ulm, Germany and Newcastle upon Tyne, UK, and has an MBA from INSEAD in France. He started his professional career as a consultant at BCG.
Areas of Interest
- AI
- Autonomous Mobility
- Computer Vision
- Digital Technologies
- Drug Discovery
- Fintech
- Genetics
- Manufacturing Technologies
- Nuclear Fusion
- Quantum Technologies
- Regenerative Medicine
- Robotics
- Semiconductors
Active Investments
Previous Investments
ArsenalBio develops programmable CAR-T therapies using genetic circuits, CRISPR, AI, and data analytics for cancer treatment
ArsenalBio develops programmable cell therapies using genetic circuits to enhance CAR-T therapies for solid tumors. By controlling specificity, on-tumor activation, potency, and durability, the company leverages CRISPR, AI, and data analytics to reprogram T cells and identify new drug candidates for improved cancer treatment.
CEO
Ken Drazan
Sectors
Healthcare
Stage
Series C
HQ
California
Deal Team
Wolfgang Seibold
Joanna Soroka
Bioptimus is building a universal multi-scale, multi-modal Foundation Model for Biology to revolutionize biomedicine research.
Bioptimus is building the world’s first universal multi-scale, multi-modal Foundation Model for Biology. By leveraging expertise from Google DeepMind and the unique MOSAIC dataset, Bioptimus aims to uncover intricate relationships across biological systems at unprecedented scales. This groundbreaking approach is poised to drive the next frontier in biomedicine research.
CEO
Jean-Philippe Vert
Sectors
Digital
Healthcare
Stage
Series A
HQ
Paris
Deal Team
Wolfgang Seibold
Joanna Soroka
Marina Du
Aditi Purandare
Cure51 is building the first global database of cancer survivors to uncover new life-saving medicines.
Cure51 is creating the world’s first global, diversified clinical and molecular database of cancer survivors to uncover life-saving medicines. Through a collaborative network, multiomics, and special biology, it aims to identify therapeutic targets for cancer treatment. The company, co-created with oncology centers, focuses on three cancer indications.
CEO
Nicolas Wolikow
Sectors
Healthcare
Stage
Seed
HQ
Paris
Deal Team
Wolfgang Seibold
Joanna Soroka
Marina Du
GROW Inc’s technology and services solutions enable super funds and fund managers to optimise operations and step into the future of financial services.
Grow Inc provides wealth administration platform technology and services to the wealth management industry in Australia. Grow’s wealth administration platform helps superannuation funds maintain member records, process fund allocation changes, create workflows and perform calculations based on business rules. Grow also provides administration services including the mailing out and receiving of physical forms, contact centre management and member communication.
CEO
Mathew Keeley
Sectors
Digital
Stage
Series D
HQ
Syndey
Deal Team
Wolfgang Seibold
Galina Sagan
Elena Ballesteros
Digital health platform using real-time health data to improve clinical care and research
Digital health platform enabling ‘Hospital at Home’ remotely collect patient-generated data, greater access to care outside of a conventional setting, improving efficiency and empowering patients to better manage their own health Companion App (SaMD) secure, scalable and fully compliant platform accelerates time to market for pharma and medtech customers’ regulated digital health products
Digital Clinical Trial (DCT) easy-to-build and digital-first clinical trial platform that deploys trial at speed, achieve higher accuracy with continuous data collection and near real-time reporting.
CEO
Dan Vahdat
Sectors
Digital
Healthcare
Stage
Series D
HQ
London
Deal Team
Wolfgang Seibold
Development of thermal interface materials based on nanostructured copper to enhance heat transfer from high-performance chips.
NovoLINC develops next-generation thermal interface materials based on nanostructured copper to dramatically enhance heat transfer from high-performance chips. As AI workloads push chip power densities higher, making thermal management a key bottleneck in data-center design – NovoLINC’s technology delivers significantly lower thermal resistance and let’s chips run cooler and more reliably.
CEO
Ning Li
Sectors
Digital
Stage
Stage +
HQ
Pittsburgh
Deal Team
Wolfgang Seibold
Vamsi Patti
Pratik Malhotra
The AI operating system for manufacturing and supply chain operations.
Exited October 2025
Regrello is building an AI-powered supply chain manager that combines traditional and generative AI to automate end-to-end operational and back-office workflows. Regrello auto generates process diagrams and eliminates manual work, accelerates cycle times, and transforms fragmented processes into intelligent, adaptable systems built for speed, scale, and efficiency.
CEO
Aman Naimat
Sectors
Digital
Industrial
Stage
Series A
HQ
California
Deal Team
Wolfgang Seibold
Jan Marchewski
Pratik Malhotra
Relation Therapeutics combines AI, genomic medicine, and Lab-in-the-Loop to build disease maps and discover novel drug targets.
Relation Therapeutics is a drug discovery company focused on genomics, combining advanced ActiveGraph AI models with Lab-in-the-Loop. This integration allows for seamless single-cell analysis at scale, creating rich maps of disease biology to identify novel drug targets. Their approach accelerates drug discovery by linking genomics and AI-driven insights.
CEO
David Roblin
Sectors
Digital
Healthcare
Stage
Seed
HQ
London
Deal Team
Wolfgang Seibold
Joanna Soroka
Marina Du
Fully automated and ultra-scalable hybrid cloud platform enabling big compute for breakthroughs in science and engineering.
Developer of cloud-based infrastructure platform designed to facilitate scientific and engineering simulations. The company’s platform provides an infinite scale, customization tools, and the ability to make adjustments optimized for specific workloads in order to decrease turnaround times, enabling businesses to transform information technology into unified, agile environments while improving the total outcome.
CEO
Joris Poort
Sectors
Digital
Stage
Series C
HQ
California
Deal Team
Wolfgang Seibold
Galina Sagan
Scipher Medicine uses transcriptomics and network biology to uncover molecular signatures for autoimmune disease diagnostics and drug discovery.
Scipher Medicine leverages transcriptomics and real-world evidence to build a precision immunology platform for complex diseases. Combining interactome and network biology with proprietary patient transcriptomics data, the platform uncovers unique molecular disease signatures in autoimmune disease patients, advancing diagnostics, drug discovery, and personalized treatment development.
CEO
Reginald Seeto
Sectors
Healthcare
Stage
Series D
HQ
Massachusetts
Deal Team
Wolfgang Seibold
Joanna Soroka
Data analytics solution to support healthcare professionals by maximizing power of data-driven precision medicine.
Exited
Sophia Genetics offers a decentralized, AI-driven data analytics platform integrating genomics, radiology, and clinical data. Covering cancer, cardiology, nephropathies, and hereditary diseases, the platform connects over 750 global health institutions. It seamlessly integrates into existing workflows, ensuring data ownership while powering precision medicine and actionable insights for healthcare providers and biopharma.
CEO
Jurgi Camblong
Sectors
Healthcare
Stage
Exited
HQ
Massachusetts
Deal Team
Wolfgang Seibold
Revolutionizing Cyber Security with an AI-powered Command Center.
StrikeReady’s functionality scope goes far beyond SoC automation co-pilots, while combining elements of SIEM (proactive), SOAR (reactive/defensive) and workflow automation solutions with AI-led agent-based assistance.
StrikeReady augments security professionals’ work by providing a common workspace that empowers faster, better decision-making.
CEO
Yasir Khalid
Sectors
Digital
Stage
Series A
HQ
Texas
Deal Team
Wolfgang Seibold
Galina Sagan
Tobias Graf
Agriculture intelligence company offering high precision aerial surveillance imagery to prevent crop yield loss.
Developer of an AI-powered crop analytics platform designed to unlock demand intelligence for agribusiness. The company’s platform uses computer vision, data science, and deep learning algorithms to make informed decisions by detecting early symptoms of weeds, uneven emergence, nutrient deficiencies, disease or insect infestations, water damage, and machinery problems, enabling farmers to acquire accurate insights to address issues while increasing yields.
CEO
Opher Flohr
Sectors
Digital
Environment
Stage
Series D
HQ
California
Deal Team
Wolfgang Seibold
Galina Sagan
Developer of a fusion energy system intended to create a limitless source of zero-emission power for a sustainable future with an improved stellarator approach.
Thea is a planar coil stellarator design revolutionizing fusion through arrays of planar magnets that enable new ways of designing, manufacturing, and dynamically controlling stellarators to achieve commercial fusion in a cost-competitive way.
CEO
Brian Berzin
Sectors
Environment
Stage
Series A
HQ
Texas
Deal Team
Wolfgang Seibold
Tobias Jahn
Elena Ballesteros
Tobias Graf